Calquence (acalabrutinib) is a targeted therapy for certain cancers. Each capsule contains 100 mg of acalabrutinib. This pack includes 60 capsules./Description: Calquence is an oral medication used to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or mantle cell lymphoma (MCL). It works by inhibiting Bruton tyrosine kinase (BTK), a protein essential for the growth and survival of malignant B-cells. By blocking BTK, Calquence helps slow the progression of these cancers. The recommended dosage is 100 mg taken orally approximately every 12 hours. It's important to follow the prescribed dosing schedule and consult with a healthcare provider for personalized advice.. Please Note that product description, color, ingredients, package and other information maybe different from the original pack kindly check the product for more accurate details.
